Form 4 holding
Chief Financial Officer
Syros Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 18 Nov 2024
- Price
- $2.09
- Ownership
- Direct
Jason Haas - Chief Financial Officer at Syros Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- SYRS
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jason Haas since 10 Jul 2025
Reported holdings for Jason Haas in Syros Pharmaceuticals, Inc.
Form 4 holding
Chief Financial Officer
Syros Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 31 Oct 2024
- Price
- $2.09
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jason Haas in Syros Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.